CUSIP 78397T202COM NEWSABSQ4 2025
12 filings · latest Mar 11, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 11.42M | $42.71M |
| 2 | Commodore Capital LP | 4.40M | $16.46M |
| 3 | Ra Capital Management, L.P. | 4.40M | $16.46M |
| 4 | Woodline Partners LP | 2.85M | $10.66M |
| 5 | Spruce Street Capital LP | 2.20M | $8.22M |
| 6 | Sessa Capital Im, L.P. | 2.20M | $8.22M |
| 7 | Blackstone Inc. | 2.14M | $8.02M |
| 8 | Vanguard Group Inc | 1.85M | $6.91M |
| 9 |
| 4 | Jan 22, 2026 | Perceptive Advisors LLC | 13G | 7.3% | 3.47M | SEC |
| 5 | Nov 14, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 5.17M | SEC |
| 6 | Nov 14, 2025 | Woodline Partners LP | 13G | 9.9% | 7.13M | SEC |
| 7 | Oct 3, 2025 | Commodore Capital LP | 13G | 9.9% | 4.52M | SEC |
| 8 | Oct 3, 2025 | Ra Capital Management, L.P. | 13D | 9.9% | — | SEC |
| 9 | Oct 3, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G | 10.0% | 25.93M | SEC |
| 10 | Feb 14, 2025 | Rtw Investments, LP | 13G/A | 10.0% | 1.02M | SEC |
See the full Schedule 13D/13G history for Sab Biotherapeutics Inc.
Unlock full history| 803.2K |
| $3.00M |
| 10 | Propel Bio Management, LLC | 652.9K | $2.44M |